Recently Featured

Trump Administration Struggles to Shift Vaccine Politics Focus

March 14, 2026
The Trump administration is facing challenges in diverting attention from contentious vaccine policies to more favorable topics such as drug pricing and public health initiatives. Despite efforts to pivot the narrative, vaccine-related issues continue to dominate the healthcare news landscape, indicating a persistent public interest and concern surrounding vaccination strategies. This ongoing focus on vaccine…

FUJIFILM Biotechnologies Unveils ShunzymeX Precision Purification Technology

March 14, 2026
FUJIFILM Biotechnologies has introduced ShunzymeX precision purification technology, designed to enhance downstream processing for complex biologics. This innovative solution is set to be showcased at the Festival of Biologics conference in San Diego, highlighting its potential impact on the industry. Developed in collaboration with the University of Edinburgh, ShunzymeX utilizes a proprietary protease that simplifies…

FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters

March 13, 2026
The FDA has intensified its enforcement actions by issuing warning letters to 30 telehealth companies involved in the compounding of GLP-1 drugs, signaling a significant regulatory shift in this space. In these letters, the agency has threatened legal action without further notice, underscoring its commitment to ensuring compliance with established pharmaceutical standards. This crackdown comes…

Ongoing Cases